Skip to main content

Table 1 Association of ASMTL-AS1 expression with clinical features in 68 triple-negative breast cancer patients

From: A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple‐negative breast cancer

Parameters Total (n = 68) ASMTL-AS1 expression P value
Low (n = 34) High (n = 34)
Age (years)
 ≤ 40 21 9 12 0.431
 > 40 47 25 22
Menopause
 Yes 28 12 16 0.324
 No 40 22 18
Tumor size (cm)
 ≤ 2 32 8 23 <0.001
 > 2 36 25 11
Lymph node metastasis
 Negative 25 7 18 0.006
 Positive 43 27 16
TNM stage
 I-II 23 2 21 <0.001
 III 45 32 13